(Q42539955)

2 November 2017

title

Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors (English)

1 reference

2 November 2017

Gourlet P

1

1 reference

2 November 2017

Rathé J

2

1 reference

2 November 2017

De Neef P

3

1 reference

2 November 2017

Cnudde J

4

1 reference

2 November 2017

Vandermeers-Piret MC

5

1 reference

2 November 2017

Waelbroeck M

6

1 reference

2 November 2017

Robberecht P

7

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

European Journal of Pharmacology

2 November 2017

published in

1 reference

2 November 2017

volume

354

1 reference

2 November 2017

issue

1

1 reference

2 November 2017

page(s)

105-111

1 reference

Peptide analogues of the anaphylatoxin C3a; syntheses and properties.

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Haemodynamics of pelvic nerve induced penile erection in the dog: possible mediation by vasoactive intestinal polypeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Dysfunction of the gastrointestinal tract. Vasoactive intestinal peptide in peristalsis and sphincter function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Design and development of a vasoactive intestinal peptide analog as a novel therapeutic for bronchial asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Properties of the VIP-PACAP type II receptor stably expressed in CHO cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Preferential cleavage of amino- and carboxyl-terminal oligopeptides from vasoactive intestinal polypeptide by human recombinant enkephalinase (neutral endopeptidase, EC 3.4.24.11).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

The activation of adenylate cyclase by pituitary adenylate cyclase activating polypeptide (PACAP) via helodermin-preferring VIP receptors in human SUP-T1 lymphoblastic membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Development of high affinity selective VIP1 receptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

In vitro properties of a high affinity selective antagonist of the VIP1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP-27, but not PACAP-38) degradation by the neutral endopeptidase EC 3.4.24.11

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

A fatty neuropeptide. Potential drug for noninvasive impotence treatment in a rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Development of helix-based vasoactive intestinal peptide analogues: identification of residues required for receptor interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Binding of vasoactive intestinal polypeptide to dispersed enterocytes results in rapid removal of the NH2-terminal histidyl residue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

A highly sensitive adenylate cyclase assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Differential signal transduction by five splice variants of the PACAP receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900435-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(98)00435-X

1 reference

2 November 2017

1 reference